Atreca, Inc. Common Equity (Total)

Common Equity (Total) of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Common Equity (Total) growth rates and interactive chart.


Highlights and Quick Summary

  • Common Equity (Total) for the quarter ending September 30, 2022 was $96.3 Million (a -16.45% decrease compared to previous quarter)
  • Year-over-year quarterly Common Equity (Total) decreased by -37.87%
  • Annual Common Equity (Total) for 2021 was $155 Million (a -35.99% decrease from previous year)
  • Annual Common Equity (Total) for 2020 was $242 Million (a 29.48% increase from previous year)
  • Annual Common Equity (Total) for 2019 was $187 Million (a -300.95% decrease from previous year)
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Common Equity (Total) of Atreca, Inc.

Most recent Common Equity (Total)of BCEL including historical data for past 10 years.

Interactive Chart of Common Equity (Total) of Atreca, Inc.

Atreca, Inc. Common Equity (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $96.25 $115.2 $137.78
2021 $154.93 $175.43 $198.6 $221.4 $154.93
2020 $242.06 $261.28 $154.12 $170.14 $242.06
2019 $186.95 $205.0 $218.88 $186.95
2018 $-93.03 $-93.03
2017 $-56.57

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology